Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
78.79
-9.26 (-10.52%)
At close: Aug 12, 2026, 4:00 PM EDT
79.11
+0.32 (0.41%)
After-hours: Aug 12, 2026, 7:58 PM EDT
Liquidia Revenue
Liquidia had revenue of $171.68M in the quarter ending June 30, 2026, with 1,842.73% growth. This brings the company's revenue in the last twelve months to $450.91M, up 2,233.65% year-over-year. In the year 2025, Liquidia had annual revenue of $158.32M with 1,031.18% growth.
Revenue (ttm)
$450.91M
Revenue Growth
+2,233.65%
P/S Ratio
15.64
Revenue / Employee
$2,087,532
Employees
216
Market Cap
7.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.32M | 144.32M | 1,031.18% |
| Dec 31, 2024 | 14.00M | -3.49M | -19.97% |
| Dec 31, 2023 | 17.49M | 1.55M | 9.75% |
| Dec 31, 2022 | 15.94M | 3.08M | 23.98% |
| Dec 31, 2021 | 12.85M | 12.11M | 1,637.77% |
| Dec 31, 2020 | 739.63K | -7.33M | -90.84% |
| Dec 31, 2019 | 8.07M | 5.37M | 198.20% |
| Dec 31, 2018 | 2.71M | -4.55M | -62.70% |
| Dec 31, 2017 | 7.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 5.02B |
| Dr. Reddy's Laboratories | 3.50B |
| Neurocrine Biosciences | 3.37B |
| Amneal Pharmaceuticals | 3.12B |
| Hims & Hers Health | 2.58B |
| Alkermes | 1.67B |
| Lantheus Holdings | 1.56B |
| Indivior Pharmaceuticals | 1.33B |
LQDA News
- 14 hours ago - Liquidia Earnings Call Transcript: Q2 2026 - Transcripts
- 14 hours ago - Liquidia Earnings release: Q2 2026 - Filings
- 14 hours ago - Liquidia Quarterly report: Q2 2026 - Filings
- 14 hours ago - Liquidia Slides: Q2 2026 - Filings
- 16 hours ago - Liquidia Corporation Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 14 days ago - Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026 - GlobeNewsWire
- 20 days ago - Liquidia price target raised to $130 from $75 at H.C. Wainwright - TheFly
- 6 weeks ago - Liquidia downgraded to Neutral from Buy at BofA - TheFly